Published in J Mol Biol on September 18, 2012
Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev (2014) 1.10
β-hairpin-mediated nucleation of polyglutamine amyloid formation. J Mol Biol (2013) 0.96
Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance. Biochemistry (2014) 0.93
Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis. FEBS J (2013) 0.90
Aggregation behavior of chemically synthesized, full-length huntingtin exon1. Biochemistry (2014) 0.87
N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice. Neuron (2015) 0.83
Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity. PLoS One (2014) 0.81
Huntingtin N-Terminal Monomeric and Multimeric Structures Destabilized by Covalent Modification of Heteroatomic Residues. Biochemistry (2015) 0.81
A serendipitous survey of prediction algorithms for amyloidogenicity. Biopolymers (2013) 0.79
CAMELOT: A machine learning approach for coarse-grained simulations of aggregation of block-copolymeric protein sequences. J Chem Phys (2015) 0.78
The emerging role of the first 17 amino acids of huntingtin in Huntington's disease. Biomol Concepts (2015) 0.76
Investigating Mutations to Reduce Huntingtin Aggregation by Increasing Htt-N-Terminal Stability and Weakening Interactions with PolyQ Domain. Comput Math Methods Med (2016) 0.76
An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation. J Biol Chem (2016) 0.76
Electrostatic Repulsion Governs TDP-43 C-terminal Domain Aggregation. PLoS Biol (2016) 0.76
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models. Sci Rep (2017) 0.75
The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR (1994) 16.20
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Aggresomes: a cellular response to misfolded proteins. J Cell Biol (1998) 11.24
Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem (2000) 11.10
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell (1997) 7.59
Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol (2011) 4.98
SUMO modification of Huntingtin and Huntington's disease pathology. Science (2004) 3.85
Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev (2010) 3.69
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A (2002) 3.56
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci (2008) 3.54
Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell (2001) 3.41
Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol (2001) 2.80
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol (2009) 2.77
Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. Biochemistry (2001) 2.64
Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet (2007) 2.51
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron (2009) 2.43
Inside the human cancer tyrosine phosphatome. Nat Rev Cancer (2011) 2.38
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol (2009) 2.16
Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol (2005) 2.14
An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice. Neuron (2011) 2.00
Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat Chem Biol (2011) 1.97
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet (2006) 1.96
Mutational analysis of the structural organization of polyglutamine aggregates. Proc Natl Acad Sci U S A (2002) 1.89
Thermodynamics of A beta(1-40) amyloid fibril elongation. Biochemistry (2005) 1.81
Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay. Methods Enzymol (2006) 1.66
Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat Struct Mol Biol (2011) 1.60
Expanding the proteome: disordered and alternatively folded proteins. Q Rev Biophys (2011) 1.60
Alanine scanning mutagenesis of Abeta(1-40) amyloid fibril stability. J Mol Biol (2006) 1.55
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils. J Am Chem Soc (2011) 1.37
Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence. J Mol Biol (2012) 1.37
Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity. J Biol Chem (2009) 1.34
Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J Cell Biol (2005) 1.24
Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity. J Biol Chem (2006) 1.19
Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol (2011) 1.17
Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci (2006) 1.16
Structural features and domain organization of huntingtin fibrils. J Biol Chem (2012) 1.04
Inhibiting the nucleation of amyloid structure in a huntingtin fragment by targeting α-helix-rich oligomeric intermediates. J Mol Biol (2011) 1.03
The impact of ataxin-1-like histidine insertions on polyglutamine aggregation. Protein Eng Des Sel (2009) 0.97
Assays for studying nucleated aggregation of polyglutamine proteins. Methods (2011) 0.97
Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation. Hum Mol Genet (2011) 0.96
Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties. Biochemistry (2012) 0.94
Inhibition of polyglutamine aggregate cytotoxicity by a structure-based elongation inhibitor. FASEB J (2004) 0.90
How post-translational modifications influence amyloid formation: a systematic study of phosphorylation and glycosylation in model peptides. Chemistry (2010) 0.86
Phosphorylation as a tool to modulate aggregation propensity and to predict fibril architecture. Chembiochem (2011) 0.81
Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils. Biochemistry (2012) 0.79
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A (2002) 3.56
Dynamic nuclear polarization at high magnetic fields. J Chem Phys (2008) 3.52
Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. J Mol Biol (2004) 3.05
Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell (2004) 2.89
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol (2009) 2.77
Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol (2007) 2.75
Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A (2002) 2.62
Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry (2002) 2.59
Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet (2002) 2.44
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron (2009) 2.43
Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem (2004) 2.35
Amyloid adhesins are abundant in natural biofilms. Environ Microbiol (2007) 2.35
Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol (2005) 2.14
Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions. Proc Natl Acad Sci U S A (2006) 2.00
Tilt angles of transmembrane model peptides in oriented and non-oriented lipid bilayers as determined by 2H solid-state NMR. Biophys J (2004) 1.98
Mutational analysis of the structural organization of polyglutamine aggregates. Proc Natl Acad Sci U S A (2002) 1.89
Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A (2005) 1.87
Thermodynamics of A beta(1-40) amyloid fibril elongation. Biochemistry (2005) 1.81
Kinetic analysis of beta-amyloid fibril elongation. Anal Biochem (2004) 1.78
Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. J Mol Biol (2010) 1.74
Dynamic nuclear polarization-enhanced solid-state NMR spectroscopy of GNNQQNY nanocrystals and amyloid fibrils. Phys Chem Chem Phys (2010) 1.72
Cryogenic sample exchange NMR probe for magic angle spinning dynamic nuclear polarization. J Magn Reson (2009) 1.66
Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay. Methods Enzymol (2006) 1.66
Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat Struct Mol Biol (2011) 1.60
polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc Natl Acad Sci U S A (2005) 1.57
Alanine scanning mutagenesis of Abeta(1-40) amyloid fibril stability. J Mol Biol (2006) 1.55
Lipid dependence of membrane anchoring properties and snorkeling behavior of aromatic and charged residues in transmembrane peptides. Biochemistry (2002) 1.54
Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy. Biochemistry (2005) 1.46
Structural properties of Abeta protofibrils stabilized by a small molecule. Proc Natl Acad Sci U S A (2005) 1.40
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils. J Am Chem Soc (2011) 1.37
Observation of a low-temperature, dynamically driven structural transition in a polypeptide by solid-state NMR spectroscopy. J Am Chem Soc (2009) 1.35
Hydrophobic mismatch between helices and lipid bilayers. Biophys J (2003) 1.28
Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange--mass spectrometry with on-line proteolytic fragmentation. J Mol Biol (2006) 1.26
Molecular basis for passive immunotherapy of Alzheimer's disease. Proc Natl Acad Sci U S A (2007) 1.26
Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet (2006) 1.25
Abeta protofibrils possess a stable core structure resistant to hydrogen exchange. Biochemistry (2003) 1.23
Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies. Proteins (2005) 1.22
Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc Natl Acad Sci U S A (2006) 1.21
In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence. J Biol Chem (2007) 1.19
Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci (2009) 1.18
Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol (2011) 1.17
An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking. Biochemistry (2004) 1.17
Molecular modeling of the core of Abeta amyloid fibrils. Proteins (2004) 1.16
Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice. J Biol Chem (2010) 1.16
Imaging polyglutamine deposits in brain tissue. Methods Enzymol (2006) 1.13
Scanning cysteine mutagenesis analysis of Abeta-(1-40) amyloid fibrils. J Biol Chem (2005) 1.12
Structural insights into the interaction between prion protein and nucleic acid. Biochemistry (2006) 1.10
Hydrogen/deuterium exchange mass spectrometry--a window into amyloid structure. Acc Chem Res (2006) 1.07
Structural complexity of a composite amyloid fibril. J Am Chem Soc (2011) 1.07
Inhibiting the nucleation of amyloid structure in a huntingtin fragment by targeting α-helix-rich oligomeric intermediates. J Mol Biol (2011) 1.03
High-resolution solid-state NMR structure of alanyl-prolyl-glycine. J Magn Reson (2009) 1.02
Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins. J Virol (2012) 1.01
Effect of loop length variation on quadruplex-Watson Crick duplex competition. Nucleic Acids Res (2008) 1.00
Assays for studying nucleated aggregation of polyglutamine proteins. Methods (2011) 0.97
The impact of ataxin-1-like histidine insertions on polyglutamine aggregation. Protein Eng Des Sel (2009) 0.97
β-hairpin-mediated nucleation of polyglutamine amyloid formation. J Mol Biol (2013) 0.96
Structural characterization of the caveolin scaffolding domain in association with cholesterol-rich membranes. Biochemistry (2011) 0.95
CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J Neurosci (2006) 0.95
Lipid dynamics and protein-lipid interactions in 2D crystals formed with the β-barrel integral membrane protein VDAC1. J Am Chem Soc (2012) 0.95
Nature of the amyloid-beta monomer and the monomer-oligomer equilibrium. J Biol Chem (2011) 0.94
Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties. Biochemistry (2012) 0.94
Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance. Biochemistry (2014) 0.93
Hydrogen/deuterium exchange mass spectrometry analysis of protein aggregates. Methods Enzymol (2006) 0.93
Combined experimental/theoretical refinement of indole ring geometry using deuterium magnetic resonance and ab initio calculations. J Am Chem Soc (2003) 0.93
Importance of tensor asymmetry for the analysis of 2H NMR spectra from deuterated aromatic rings. J Am Chem Soc (2005) 0.92
Multipole-multimode Floquet theory of rotational resonance width experiments: 13C-13C distance measurements in uniformly labeled solids. J Chem Phys (2006) 0.91
Inhibition of polyglutamine aggregate cytotoxicity by a structure-based elongation inhibitor. FASEB J (2004) 0.90
Enhanced correction methods for hydrogen exchange-mass spectrometric studies of amyloid fibrils. Protein Sci (2003) 0.89
Structural variations in the cross-beta core of amyloid beta fibrils revealed by deep UV resonance Raman spectroscopy. J Am Chem Soc (2010) 0.88
Biophysical underpinnings of the repeat length dependence of polyglutamine amyloid formation. J Biol Chem (2014) 0.87
Aggregation behavior of chemically synthesized, full-length huntingtin exon1. Biochemistry (2014) 0.87
Time averaging of NMR chemical shifts in the MLF peptide in the solid state. J Am Chem Soc (2010) 0.86
Nucleation of huntingtin aggregation in cells. Nat Chem Biol (2006) 0.85
Amyloid-like fibrils from a domain-swapping protein feature a parallel, in-register conformation without native-like interactions. J Biol Chem (2011) 0.84
Analysis of amyloid fibril structure by scanning cysteine mutagenesis. Methods Enzymol (2006) 0.83
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation (2010) 0.82